CYP19A1 and neoplasm: Two proven treatment options exist: tamoxifen, a selective ER modulator which blocks 17ß-estradiol (E2) binding to ER to stop tumor growth, and aromatase inhibitors (AI), which block the aromatase enzyme that prevents the conversion of androgens to estrogens.